159
Views
4
CrossRef citations to date
0
Altmetric
Original Research

The Role of Radiotherapy in the Treatment of Retroperitoneal Lymph Node Metastases from Colorectal Cancer

, , , , , & show all
Pages 8913-8921 | Published online: 23 Sep 2020

References

  • Favoriti P, Carbone G, Greco M, et al. Worldwide burden of colorectal cancer: a review. Updates Surg. 2016;68(1):7–11. doi:10.1007/s13304-016-0359-y27067591
  • Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490–1502. doi:10.1016/S0140-6736(13)61649-924225001
  • Lee WS, Yun SH, Chun HK, et al. Pulmonary resection for metastases from colorectal cancer: prognostic factors and survival. Int J Colorectal Dis. 2007;22(6):699–704. doi:10.1007/s00384-006-0218-217109105
  • Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol. 1997;15(3):938–946. doi:10.1200/JCO.1997.15.3.9389060531
  • Choi PW, Kim HC, Kim AY, et al. Extensive lymphadenectomy in colorectal cancer with isolated para-aortic lymph node metastasis below the level of renal vessels. J Surg Oncol. 2010;101(1):66–71. doi:10.1002/jso.2142119842140
  • Min BS, Kim NK, Sohn SK, et al. Isolated paraaortic lymph-node recurrence after the curative resection of colorectal carcinoma. J Surg Oncol. 2008;97(2):136–140. doi:10.1002/jso.2092617963247
  • Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386–1422. doi:10.1093/annonc/mdw23527380959
  • Biasco G, Derenzini E, Grazi G, et al. Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties. Cancer Treat Rev. 2006;32(3):214–228. doi:10.1016/j.ctrv.2005.12.01116546323
  • Saltz LB. Metastatic colorectal cancer: is there one standard approach? Oncology. 2005;19(9):1147–54;discussion 54, 57–8, 60.
  • Ho TW, Mack LA, Temple WJ. Operative salvage for retroperitoneal nodal recurrence in colorectal cancer: a systematic review. Ann Surg Oncol. 2011;18(3):697–703. doi:10.1245/s10434-010-1322-720853031
  • Kim M-S, Cho CK, Yang KM, et al. Stereotactic body radiotherapy for isolated paraaortic lymph node recurrence from colorectal cancer. World J Gastroenterol. 2009;15(48):6091–6095. doi:10.3748/wjg.15.609120027683
  • Van Cutsem E, Nordlinger B, Adam R, et al. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer. 2006;42(14):2212–2221. doi:10.1016/j.ejca.2006.04.01216904315
  • Dhir M, Sasson AR. Surgical management of liver metastases from colorectal cancer. J Oncol Pract. 2016;12(1):33–39. doi:10.1200/JOP.2015.00940726759464
  • Gonzalez M, Poncet A, Combescure C, et al. Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol. 2013;20(2):572–579. doi:10.1245/s10434-012-2726-323104709
  • Yeo S-G, Kim DY, Kim TH, et al. Curative chemoradiotherapy for isolated retroperitoneal lymph node recurrence of colorectal cancer. Radiother Oncol. 2010;97(2):307–311. doi:10.1016/j.radonc.2010.05.02120667611
  • Hashimoto M, Komatsu H, Naruse Y, et al. Resection of paraaortic lymph node metastasis of colon cancer with graft replacement. Hepato Gastroenterol. 2003;50(51):709–710.
  • Cameron MG, Kersten C, Vistad I, et al. Palliative pelvic radiotherapy of symptomatic incurable rectal cancer – a systematic review. Acta Oncol. 2014;53(2):164–173. doi:10.3109/0284186X.2013.83758224195692
  • Marks LB, Ten Haken RK, Martel MK. Guest editor’s introduction to QUANTEC: a users guide. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S1–S2. doi:10.1016/j.ijrobp.2009.08.07520171501
  • Agarwal JP, Nemade B, Murthy V, et al. Hypofractionated, palliative radiotherapy for advanced head and neck cancer. Radiother Oncol. 2008;89(1):51–56. doi:10.1016/j.radonc.2008.06.00718649963
  • Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92(3):205–216.10655437
  • Johnson B, Jin Z, Haddock MG, et al. A curative-intent trimodality approach for isolated abdominal nodal metastases in metastatic colorectal cancer: update of a single-institutional experience. Oncologist. 2018;23(6):679–685. doi:10.1634/theoncologist.2017-045629445027
  • Isozaki Y, Yamada S, Kawashiro S, et al. Carbon-ion radiotherapy for isolated para-aortic lymph node recurrence from colorectal cancer. J Surg Oncol. 2017;116(7):932–938. doi:10.1002/jso.2475728727901
  • Lee J, Chang JS, Shin SJ, et al. Incorporation of radiotherapy in the multidisciplinary treatment of isolated retroperitoneal lymph node recurrence from colorectal cancer. Ann Surg Oncol. 2015;22(5):1520–1526. doi:10.1245/s10434-014-4363-525589152
  • Gagniere J, Dupre A, Chabaud S, et al. Retroperitoneal nodal metastases from colorectal cancer: curable metastases with radical retroperitoneal lymphadenectomy in selected patients. Eur J Surg Oncol. 2015;41(6):731–737. doi:10.1016/j.ejso.2015.03.22925899983
  • Taylor WE, Donohue JH, Gunderson LL, et al. The mayo clinic experience with multimodality treatment of locally advanced or recurrent colon cancer. Ann Surg Oncol. 2002;9(2):177–185. doi:10.1007/BF0255737111888876
  • Wong JS, Tan GH, Teo MC. Management of para-aortic lymph node metastasis in colorectal patients: a systemic review. Surg Oncol. 2016;25(4):411–418. doi:10.1016/j.suronc.2016.09.00827916174
  • Evans MD, Escofet X, Karandikar SS, Stamatakis JD. Outcomes of resection and non-resection strategies in management of patients with advanced colorectal cancer. World J Surg Oncol. 2009;7(1):28. doi:10.1186/1477-7819-7-2819284542
  • Eisenberger A, Whelan RL, Neugut AI. Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review. Int J Colorectal Dis. 2008;23(6):559–568. doi:10.1007/s00384-008-0456-618330581